Literature DB >> 10216262

Molecular cloning of the human Nurr1 gene: characterization of the human gene and cDNAs.

H Ichinose1, T Ohye, T Suzuki, C Sumi-Ichinose, T Nomura, Y Hagino, T Nagatsu.   

Abstract

Nurr1 is a member of the nuclear receptor superfamily of transcription factors that is expressed predominantly in the central nervous system, including developing dopaminergic neurons. Recently, it was demonstrated that Nurr1 is critical for midbrain dopaminergic cell differentiation. In order to investigate a possible relation of Nurr1 with the pathogenesis of Parkinson's disease or other neuropsychiatric disorders, we have cloned and characterized the human Nurr1 gene. The gene exists as a single copy in the human genome and comprises eight exons spanning 8kb. We determined the complete nucleotide sequence and flanking regions of the gene. Potential regulatory regions included consensus binding sites for NF-kappaB, CREB, and Sp1. Isolation of human Nurr1 cDNAs from fetal brain suggested the presence of a new splicing variant of Nurr1 in the human brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10216262     DOI: 10.1016/s0378-1119(99)00065-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  13 in total

1.  LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.

Authors:  Ha Nam Nguyen; Blake Byers; Branden Cord; Aleksandr Shcheglovitov; James Byrne; Prachi Gujar; Kehkooi Kee; Birgitt Schüle; Ricardo E Dolmetsch; William Langston; Theo D Palmer; Renee Reijo Pera
Journal:  Cell Stem Cell       Date:  2011-03-04       Impact factor: 24.633

Review 2.  Nuclear receptors in neural stem/progenitor cell homeostasis.

Authors:  Dimitrios Gkikas; Matina Tsampoula; Panagiotis K Politis
Journal:  Cell Mol Life Sci       Date:  2017-06-21       Impact factor: 9.261

Review 3.  Nurr1-Based Therapies for Parkinson's Disease.

Authors:  Jie Dong; Song Li; Jing-Lin Mo; Huai-Bin Cai; Wei-Dong Le
Journal:  CNS Neurosci Ther       Date:  2016-03-25       Impact factor: 5.243

Review 4.  Cellular and molecular mechanisms of Parkinson's disease: neurotoxins, causative genes, and inflammatory cytokines.

Authors:  Toshi Nagatsu; Makoto Sawada
Journal:  Cell Mol Neurobiol       Date:  2006-07-06       Impact factor: 5.046

Review 5.  The aetiology of idiopathic Parkinson's disease.

Authors:  D B Ramsden; R B Parsons; S L Ho; R H Waring
Journal:  Mol Pathol       Date:  2001-12

Review 6.  Molecular Insights into NR4A2(Nurr1): an Emerging Target for Neuroprotective Therapy Against Neuroinflammation and Neuronal Cell Death.

Authors:  Md Jakaria; Md Ezazul Haque; Duk-Yeon Cho; Shofiul Azam; In-Su Kim; Dong-Kug Choi
Journal:  Mol Neurobiol       Date:  2019-01-25       Impact factor: 5.590

7.  Role of Nurr1 in the Generation and Differentiation of Dopaminergic Neurons from Stem Cells.

Authors:  Eva Rodríguez-Traver; Oscar Solís; Eva Díaz-Guerra; Óscar Ortiz; Eva Vergaño-Vera; Héctor R Méndez-Gómez; Patricia García-Sanz; Rosario Moratalla; Carlos Vicario-Abejón
Journal:  Neurotox Res       Date:  2015-12-17       Impact factor: 3.911

8.  Nurr1 represses tyrosine hydroxylase expression via SIRT1 in human neural stem cells.

Authors:  Tae Eun Kim; Ji-Seon Seo; Ji Sun Seo; Jae Won Yang; Min Woong Kim; Rukhsana Kausar; Eunhye Joe; Bo Yeon Kim; Myung Ae Lee
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

9.  NR4A2 is regulated by gastrin and influences cellular responses of gastric adenocarcinoma cells.

Authors:  Kristine Misund; Linn-Karina Myrland Selvik; Shalini Rao; Kristin Nørsett; Ingunn Bakke; Arne K Sandvik; Astrid Lægreid; Torunn Bruland; Wenche S Prestvik; Liv Thommesen
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

10.  Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer.

Authors:  Jian Wang; Zhi-Hong Yang; Hua Chen; Hua-Hui Li; Li-Yong Chen; Zhu Zhu; Ying Zou; Cong-Cong Ding; Jing Yang; Zhi-Wei He
Journal:  BMC Cancer       Date:  2016-03-31       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.